99 related articles for article (PubMed ID: 9468572)
1. Breast cancer: poor short-term prognosis in cases with moderate lymphocyte infiltration at the tumour edge: a preliminary report.
Hartveit F
Oncol Rep; 1998; 5(2):423-6. PubMed ID: 9468572
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic factors in operated breast carcinoma].
Bianco V; De Benedetto A; Simeoni F; Toto A; Paris E; Chiodini S; Marchei P
Minerva Med; 1995; 86(1-2):17-20. PubMed ID: 7753433
[TBL] [Abstract][Full Text] [Related]
3. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
[TBL] [Abstract][Full Text] [Related]
4. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
Skowronek J; Piotrowski T
Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
[TBL] [Abstract][Full Text] [Related]
5. Primary tumor location impacts breast cancer survival.
Sohn VY; Arthurs ZM; Sebesta JA; Brown TA
Am J Surg; 2008 May; 195(5):641-4. PubMed ID: 18424280
[TBL] [Abstract][Full Text] [Related]
6. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer.
Escobar PF; Patrick RJ; Rybicki LA; Hicks D; Weng DE; Crowe JP
Ann Surg Oncol; 2006 Jun; 13(6):783-7. PubMed ID: 16604475
[TBL] [Abstract][Full Text] [Related]
8. Results of conservative surgery for limited-sized infiltrating breast cancer: analysis of 962 tested patients: 24 years of experience.
Vitucci C; Tirelli C; Graziano F; Santoro E
J Surg Oncol; 2000 Jun; 74(2):108-15. PubMed ID: 10914819
[TBL] [Abstract][Full Text] [Related]
9. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
10. Integrin expression and survival in human breast cancer.
Berry MG; Gui GP; Wells CA; Carpenter R
Eur J Surg Oncol; 2004 Jun; 30(5):484-9. PubMed ID: 15135474
[TBL] [Abstract][Full Text] [Related]
11. [Molecular-biological markers as prognostic factors in breast cancer of I-IIA stage].
Stepanova EV; Zagrekova EI; Ermilova VD; Turbin AD; Petrovichev NN; Vysotskaia IV; Dbar ZhN; Pashchenko NV; Baryshnikov AIu; Lichinitser MR
Arkh Patol; 2003; 65(3):14-8. PubMed ID: 12879604
[TBL] [Abstract][Full Text] [Related]
12. Outcome after breast-conserving therapy for patients with stage I or II mucinous, medullary, or tubular breast carcinoma.
Thurman SA; Schnitt SJ; Connolly JL; Gelman R; Silver B; Harris JR; Recht A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):152-9. PubMed ID: 15093911
[TBL] [Abstract][Full Text] [Related]
13. StatBite: Breast cancer: 5-year survival rates in U.S. for selected histologic types by stage.
J Natl Cancer Inst; 2009 Oct; 101(19):1303. PubMed ID: 19755678
[No Abstract] [Full Text] [Related]
14. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
15. Survival analysis between patients with invasive ductal and invasive lobular breast cancer.
Dian D; Herold H; Mylonas I; Scholz C; Janni W; Sommer H; Friese K
Arch Gynecol Obstet; 2009 Jan; 279(1):23-8. PubMed ID: 18449551
[TBL] [Abstract][Full Text] [Related]
16. Apoptotic index: use in predicting recurrence in breast cancer patients.
Srinivas P; Abraham E; Ahamed I; Madhavan M; Vijayalakshmi NR; Nair MK; Balaram P
J Exp Clin Cancer Res; 2002 Jun; 21(2):233-8. PubMed ID: 12148584
[TBL] [Abstract][Full Text] [Related]
17. Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas.
Ménard S; Tomasic G; Casalini P; Balsari A; Pilotti S; Cascinelli N; Salvadori B; Colnaghi MI; Rilke F
Clin Cancer Res; 1997 May; 3(5):817-9. PubMed ID: 9815754
[TBL] [Abstract][Full Text] [Related]
18. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
19. Incidental finding of mammary carcinoma in lumpectomy specimens.
Tang P; Hajdu SI; Conte CC; Filardi DA
Ann Clin Lab Sci; 2003; 33(1):23-31. PubMed ID: 12661895
[TBL] [Abstract][Full Text] [Related]
20. Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?
Sinha PS; Bendall S; Bates T
Eur J Surg Oncol; 2000 Dec; 26(8):733-7. PubMed ID: 11087636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]